Join us as we transform immunology and deliver medicines that help autoimmune patients get their lives back. argenx is preparing for multi-dimensional expansion to reach more patients through a rich pipeline of differentiated assets, led by VYVGART, our first-in-class neonatal Fc receptor blocker approved for the treatment of gMG, and with the potential to treat patients across dozens of severe autoimmune diseases.
We are building a new kind of biotech company, one that maintains its roots as a science-based start-up and pushes our commitment to innovate across all corners of our business. We strive to inspire and grow our company, our partnerships, our science, and our people, because when we do, we deliver more for patients.
We areseekinga highly skilled Human Factors Expertto join our team in the development of drug/device combination products The ideal candidate will have extensive experience in human factors engineering (HFE)and usability studiesfor prefilled syringes, autoinjectors, and related delivery systems This role ensures that our products meet regulatory requirements, are safe, effective, and user-friendly for patients and healthcare professionals.
Key Responsibilities:
Strategize and lead human factors engineering activitiesthroughout thecombinationproduct development lifecycle.
Develop and execute humanfactorsstudy plans, including formative and summative usability studies, risk analyses, and validation protocols.
Collaborate with cross-functional teams (CMC,Quality, Regulatory, Clinical) to integrate user needs into design requirements.
Conduct task analyses, user research, and use-related risk assessmentstoidentifypotential use errors and mitigate risks.
Provideexpertiseon device usability for patients with chronic conditions, considering physical and cognitive limitations, in consultation with medical and clinical experts.
Prepare human factors documentationfor regulatory submissions (FDA, EMA), including Human Factors Engineering Reports
Ensure compliance with FDA guidance on human factors, ISO 62366, and other relevant standards.
Support design verification and validationactivities fordrug delivery systems such asprefilled syringes, autoinjectors, and other injection devices.
Stay current with industry trends, regulatory expectations, and best practicesin human factors and usability engineering.
Required Experience & Skills
Proventrack recordin human factors/usability engineering, project management, and cross-functional leadership
Deep understanding of human factors engineering and its application in combinationproduct development
Familiarity with global regulatory frameworksfor medical devices and combination products.
Strong interpersonal and communicationskills; ability to energize and align diverse teams.
Experience with autoinjector platforms (e.g.,YpsoMate) is a plus.
Ability to work in a cross-functional, global environment.
Company Values Alignment
Candidates should embodyargenx’score values: co-creation, humility, excellence, innovation, and empowerment.
#LI-Onsite
At argenx, all applicants are welcomed in an inclusive environment. They will receive equal consideration for employment without discrimination on the basis of race, color, religion, sex, sexual orientation, gender identity, national origin, protected veteran status, disability, or any other applicable legally protected characteristics. argenx is proud to be an equal opportunity employer.
Before you submit your application, CV or any other personal details to us, please review our argenx Privacy Notice for Job Applicants to learn more about how argenx B.V. and its affiliates (“argenx”) will handle and protect your personal data. If you have any questions or you wish to exercise your privacy rights, please contact our Global Privacy Office by email at privacy@argenx.com

argenx is a global immunology company committed to improving the lives of people living with severe autoimmune diseases. Partnering with leading academic researchers through its Immunology Innovation Program (IIP), argenx is translating immunology breakthroughs into a world-class portfolio of novel antibody-based medicines.